^
    Back
    Association details:
    Biomarker:miR-27a-3p overexpression
    Cancer:Hepatocellular Cancer
    Drug:cisplatin (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    Source:
    Biosci Rep
    Title:

    MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway

    Published date:
    06/07/2021
    Excerpt:
    ...miR-27a-3p was overexpressed in HepG2 cell...overexpression of miR-27a-3p significantly increased the inhibitor rate and apoptosis rate with cisplatin intervention.
    DOI:
    10.1042/BSR20192007